CC-93538

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
98	Eosinophilic gastrointestinal disease	20

98. Eosinophilic gastrointestinal disease

Clinical trials : 172 / Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135

trials per page:

Showing 1 to 10 of 20 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2031210574	28/07/2022	22/01/2022	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	eosinophilic esophagitis	All subjects will be administered CC-93538 at a dose of 360 mg SC once weekly.	Zhang Changliang	NULL	Pending	>= 12age old	<= 75age old	Both	22	Phase 3	Belgium;Australia;Argentina;Japan;United States of America;Canada;United Kingdom;Italy;Israel;Portug ...
2	EUCTR2020-004335-24-ES (EUCTR)	17/05/2022	24/03/2022	A study to evaluate the long-term safety of CC-93538in adult and adolescent patients who have eosino ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;Switzerland;United Kingdom;Italy;Canada;Argentina;Belgiu ...
3	EUCTR2020-004335-24-PL (EUCTR)	24/03/2022	09/12/2021	A study to evaluate the long-term safety of CC-93538in adult and adolescent patients who have eosino ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	269	Phase 3	Portugal;United States;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentina;Poland ...
4	JPRN-jRCT2021210067	04/03/2022	02/02/2022	A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLEBLIND,PLACEBO-CONTROLLED INDUCTION AND MAINTENANCE STUDY T ...	A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLEBLIND,PLACEBO-CONTROLLED INDUCTION AND MAINTENANCE STUDY T ...	Eosinophilic gastroenteritis	CC-93538is administered subcutaneously at a dose of 360 mg weekly in adults and adolescents of 12 ye ...	Zhang Changliang	NULL	Recruiting	>= 12age old	<= 75age old	Both	45	Phase 3	Japan
5	NCT05214768 (ClinicalTrials.gov)	March 4, 2022	12/1/2022	A Study to Evaluate the Efficacy and Safety of CC-93538in Adult and Adolescent Japanese Participants ...	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Induction and Maintenance Study ...	Eosinophilic Gastroenteritis	Drug: CC-93538;Drug: Placebo	Celgene	NULL	Recruiting	12 Years	75 Years	All	45	Phase 3	Japan
6	EUCTR2020-004335-24-PT (EUCTR)	24/02/2022	03/12/2021	A study to evaluate the long-term safety of CC-93538in adult and adolescent patients who have eosino ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
7	EUCTR2020-004335-24-IT (EUCTR)	08/02/2022	29/10/2021	A study to evaluate the long-term safety of CC-93538in adult and adolescent patients who have eosino ...	A Phase 3, Multicenter, Multinational, Open-Label Extension Study to evaluate the Long-Term Safety o ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Trade Name: Cendakimab Product Name: Cendakimab Product Code: [CC-93538] INN or Proposed INN: Cendakima ...	CELGENE INTERNATIONAL II SàRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
8	EUCTR2020-004335-24-DE (EUCTR)	14/01/2022	30/07/2021	A study to evaluate the long-term safety of CC-93538in adult and adolescent patients who have eosino ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
9	EUCTR2020-004336-16-ES (EUCTR)	12/01/2022	12/01/2022	A study to evaluate the efficacy and safety of CC-93538in adult and adolescent patients who have eos ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentin ...
10	EUCTR2020-004336-16-DE (EUCTR)	29/09/2021	01/02/2021	A study to evaluate the efficacy and safety of CC-93538in adult and adolescent patients who have eos ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentin ...

First Previous1 2Next Last